|
|
Volumn 284, Issue 5412, 1999, Pages 238-240
|
|
Can the placebo be the cure?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
APREPITANT;
MONOAMINE OXIDASE INHIBITOR;
MORPHOLINE DERIVATIVE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
SUBSTANCE P;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DEPRESSION;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
HUMAN;
META ANALYSIS;
METHODOLOGY;
PSYCHOPHARMACOLOGY;
RANDOMIZED CONTROLLED TRIAL;
ANTIDEPRESSIVE AGENTS;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
DEPRESSIVE DISORDER;
DOUBLE-BLIND METHOD;
HUMANS;
META-ANALYSIS;
MONOAMINE OXIDASE INHIBITORS;
MORPHOLINES;
PLACEBOS;
PSYCHOPHARMACOLOGY;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
SEROTONIN UPTAKE INHIBITORS;
SUBSTANCE P;
MLCS;
MLOWN;
|
|
EID: 0033537751
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.284.5412.238 Document Type: Article |
|
Times cited : (99)
|
|
References (0)
|
